Rossari Biotech Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ipnhf8rovq3i9lrwscvcky6y.pdf

Key Takeaways


Revenue Performance


Buzil Rossari & Institutional Cleaning

Sablok: "This business, just per se, chemicals will not grow. It will remain at that Rs. 50 crore kind of level. For this business to completely grow as a consumer-based business, we will have to give this entire set of services. And that is what the competition is doing. We have to match what the competitors are doing."

Margins & Cost Structure

Chari: "Normally, these are all seeding opportunities where we, if you see this Rs. 200 crore, practically, which is very low EBITDA, but it could create a lot of value for all of, in Rossari in terms of growth and profitability. If you remove this Rs. 200 crore, the rest of the business looks at a very, very good position."

Capacity Expansion & the EO Constraint

Chari: "We are waiting for newer EO capacity to come up in Reliance. Reliance is still not confirmed by when they will start giving. This may be a constraint till we have clarity from Reliance on the higher allocation of EO."

Product & Market Initiatives


Guidance & Commitments

CommitmentSpecificsTimeline
Capacity commissioningNew capacities at Dahej and Unitop to come online in phased mannerSome in Q4 FY25, some in Q1 FY26
Revenue from new capacityRevenue contribution to beginQ2 FY26
Buzil Rossari revenueClose FY25 at ₹250 crore plusFY25 year-end
Institutional cleaning scaleDouble current revenue to ₹450-500 crore; meaningful EBITDA contribution expected at that sizeWithin 2 years
Bangladesh geographyReach ₹100 crore revenue with ₹6-7 crore monthly salesTimeline extended, no revised date
Ethoxylation capacity utilizationFull utilization of 30,000-ton addition~3 years
Employee costRemain around current quarterly level plus/minus 10%Next year
Export growth tractionStrong traction to become visibleH2 FY26 onwards
Inventory and receivablesStreamline to be in line with or better than last yearBy FY25 year-end
Margin level for new capacities~13% plus/minus in first year; gross margin improvement expectedFirst year of operation

Key Metrics

MetricQ3 FY25
Consolidated revenue₹512.7 cr, +10.5% YoY
HPPC revenue₹390 cr, +9.6% YoY; 76% of total
TSC revenue₹95 cr, +14.5% YoY; 19% of total
AHN revenue₹28 cr, +12% YoY; 5% of total
Gross margin+137 bps YoY improvement
EBITDA margin12.6%, vs 13.7% in Q3 FY24
Consolidated EBITDA₹64.8 cr
PAT₹31.7 cr
International business growth+21% YoY for the quarter, +28% over nine months
Exports₹156 cr for the quarter, ₹405 cr for nine months
Volume growth (YTD nine months)~9–10%, with ~2% from pricing
Buzil Rossari revenue (nine months)₹200 cr, +50% YoY; full-year expectation ₹250 cr+
Buzil Rossari gross margin35–40%, down from 50–55% as product basket expanded
Ethoxylation capacity utilization80%+ overall; Unitop 80–85%, Tristar 90–95%, core ethoxylation fully utilized
New ethoxylation capacity addition30,000 tons, revenue expected from Q2 FY26
Employee additions (YoY)~190 people, of which ~120 in institutional cleaning
One-time depreciation charge₹1.5–1.6 cr in Q3; total depreciation charge ~₹3 cr
Debtor daysDown 4–5 days vs prior period